Piper Sandler, Becton Dickinson
This was the stock's third consecutive day of gains.
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...
Becton, Dickinson and Company announced it repurchased $750M in BD stock to date in FY25. In addition, the board has authorized the company to ...
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price hoisted by analysts at Piper Sandler from $275.00 to $280.00 in a research report issued on Tuesday,Benzinga reports.
After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...
Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after ...
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) announced that its board has authorized a share buyback program on ...
In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback